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Introduction
Centrosomes serve as microtubule-organizing centers and facili-
tate chromosome segregation and spindle orientation during 
cell division (Bornens, 2012; Tang and Marshall, 2012). Cen-
trosomes are also the precursors to basal bodies of cilia and are 
involved in regulation of cell cycle transitions and responses 
to cell stress and DNA damage (Krämer et al., 2004; Shimada 
and Komatsu, 2009; Kim and Dynlacht, 2013; Nakamura et al., 
2013). Cells exert tight control over centrosome number by regu-
lating assembly of the centriole pair, the core duplicating ele-
ments of the organelle (Brito et al., 2012). Centriole duplication 
occurs in a cell cycle–dependent manner and is restricted to 
only one iteration during S phase when a single nascent procen-
triole emerges orthogonally from each centriole within the pair 
(Nigg and Stearns, 2011). Errors in this process result in ab-
normal centrosome numbers that may perturb spindle orienta-
tion and chromosome segregation (Vitre and Cleveland, 2012). 
Centriole amplification—the overduplication and subsequent 
overabundance of centrioles within cells—can drive tumorigenic 
chromosomal instability and is often observed in cancer cells 
(Nigg and Raff, 2009). Conversely, too few centrioles can lead 
to a variety of ciliopathies (Bettencourt-Dias et al., 2011).
Plk4 (Polo-like kinase 4) is a conserved master regula-
tor of centriole duplication, and its overexpression induces 
centriole amplification as well as de novo centriole assembly 
(Avidor-Reiss and Gopalakrishnan, 2013). Plk4 is primarily regu-
lated by protein turnover and efficiently promotes its own de-
struction to suppress centriole overduplication (Cunha-Ferreira 
et al., 2013; Klebba et al., 2013). Unlike other Polo kinase fam-
ily members, Plk4 forms a homodimer, mediated through an 
interaction between its first two Polo boxes (PB1 and PB2; 
formerly known as the cryptic Polo box; Slevin et al., 2012). 
Upon dimerization, Plk4 extensively trans-autophosphorylates 
Plk4 (Polo-like kinase 4) and its binding partner Asterless (Asl) are essential, conserved centriole as-sembly factors that induce centriole amplification 
when overexpressed. Previous studies found that Asl acts 
as a scaffolding protein; its N terminus binds Plk4’s tan-
dem Polo box cassette (PB1-PB2) and targets Plk4 to cen-
trioles to initiate centriole duplication. However, how Asl 
overexpression drives centriole amplification is unknown. 
In this paper, we investigated the Asl–Plk4 interaction in 
Drosophila melanogaster cells. Surprisingly, the N-terminal 
region of Asl is not required for centriole duplication, but 
a previously unidentified Plk4-binding domain in the 
C terminus is required. Mechanistic analyses of the different 
Asl regions revealed that they act uniquely during the cell 
cycle: the Asl N terminus promotes Plk4 homodimerization 
and autophosphorylation during interphase, whereas the 
Asl C terminus stabilizes Plk4 during mitosis. Therefore, 
Asl affects Plk4 in multiple ways to regulate centriole du-
plication. Asl not only targets Plk4 to centrioles but also 
modulates Plk4 stability and activity, explaining the ability 
of overexpressed Asl to drive centriole amplification.
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Results
Asl forms a trimer and its C-terminal 
region targets centrioles
The oligomeric state of the scaffolding protein Asl is unknown. 
To better understand the functional interactions between Asl 
and its binding partners, we first characterized its ability to 
oligomerize. First, full-length (FL) Asl-EGFP from S2 cell 
lysates retrieved endogenous Asl by coimmunoprecipitation 
(Fig. S1 A). Second, yeast two-hybrid (Y2H) analysis of the 
three Asl functional domains (A, B, and C; Fig. 1 A) revealed 
that Asl-B and Asl-C self-interact (Fig. S1 B). Because Asl-A 
autoactivates in the Y2H system, we were unable to determine 
whether it self-associates. Interestingly, Asl-B can associate 
with Asl-C (Fig. S1 B), suggesting that Asl may adopt a folded 
conformation as different regions form intramolecular inter-
actions. Third, size-exclusion chromatography with multiangle 
laser light scattering (SEC-MALS) was used to determine the 
oligomeric states of the Asl domains (Fig. 1 B). Results sug-
gested that both Asl-A and Asl-B form homodimers (predicted 
Asl-A monomer molecular mass [MM], 43 kD; dimer MM, 
86 kD; predicted Asl-B monomer MM, 31 kD; dimer MM, 
62 kD), whereas Asl-C assembles as a homotrimer (predicted 
monomer MM, 43 kD; trimer MM, 129 kD). Indeed, computer 
analysis using MultiCoil identified several distinct regions in 
Asl-C likely to form a trimeric structure (Fig. S1 C). Thus, 
our findings suggest that Asl homo-oligomerizes via spatially 
distinct two- and three-stranded coiled-coil regions.
Next, we determined the intracellular localization of each 
Asl fragment. Because Asl oligomerizes, we eliminated the 
influence of endogenous Asl on the binding and localization of 
the Asl fragments by first depleting cells of Asl (Fig. S1 D). 
After 3 d of RNAi knockdown, we transiently expressed each 
fragment as well as FL Asl (Fig. 1 C). Asl-A and Asl-AB were 
largely diffuse and cytoplasmic and weakly localized to centri-
oles. Surprisingly, Asl-B localization was restricted to the nu-
cleus. However, Asl-C efficiently colocalized with the centriole 
marker pericentrin-like protein (PLP), as did Asl-FL and an 
Asl-BC fragment (unpublished data). Thus, the C terminus of Asl 
is required to target centrioles, as reported for its orthologue 
Cep152 (Cizmecioglu et al., 2010).
Replacement of endogenous Asl with Asl-C 
rescues centriole duplication
Asl overexpression triggers centriole amplification (Dzhindzhev 
et al., 2010; Stevens et al., 2010), although the mechanism for 
this is unclear. Therefore, we next addressed whether a spe-
cific region in Asl is sufficient for this activity by expressing 
Asl fragments (in the presence of endogenous Asl) and measur-
ing centriole numbers (Fig. S2 A). Because of their small size, 
mother and daughter centrioles cannot be distinguished within 
an engaged pair using standard light microscopy in most fly 
cells. However, by immunostaining for PLP, a protein recruited 
to the outer surface of mature centrioles (Fu and Glover, 2012; 
Mennella et al., 2012), we can accurately measure centriole loss 
(less than two spots) and amplification (greater than two spots) 
in these cells (Dzhindzhev et al., 2010; Brownlee et al., 2011). 
a region near the kinase domain, which then recruits the 
SCFSlimb/-TrCP ubiquitin (Ubi) ligase, resulting in its ubiquitina-
tion and proteasomal degradation (Cunha-Ferreira et al., 2009; 
Rogers et al., 2009; Holland et al., 2010; Guderian et al., 2010; 
Cunha-Ferreira et al., 2013; Klebba et al., 2013). However, 
during mitosis in flies, autophosphorylation is counteracted 
by Protein Phosphatase 2A (PP2A) and, consequently, Plk4 
protein levels rise (Brownlee et al., 2011). Plk4 then targets 
mitotic centrioles, appearing as a single asymmetric spot on 
each centriole (Rogers et al., 2009). Plk4 within each spot is 
thought to modify this site on a centriole, making each centri-
ole competent to spawn a single daughter centriole during the 
next S phase (Kleylein-Sohn et al., 2007).
The Drosophila melanogaster protein Asterless (Asl) is 
required for centriole duplication and its overexpression also 
induces centriole overduplication and de novo centriole assem-
bly (Varmark et al., 2007; Blachon et al., 2008; Dzhindzhev 
et al., 2010; Stevens et al., 2010). Notably, the Asl human ortho-
logue, Cep152, is linked to microcephaly (MCPH9) and Seckel 
syndrome (SCKL5; Guernsey et al., 2010; Kalay et al., 2011). 
Asl/Cep152 is a large protein containing extensive coiled-coil 
regions and acts as a platform for procentriole assembly by bind-
ing several centrosomal proteins including SAS-4/centrosomal 
P4.1-associated protein (CPAP), Cep63, Cep192, and Plk4 
(Dzhindzhev et al., 2010; Hatch et al., 2010; Cizmecioglu 
et al., 2010; Sir et al., 2011; Sonnen et al., 2013). Previous stud-
ies identified three distinct scaffolding domains within Asl, 
which we refer to as Asl-A, -B, and -C (Fig. 1 A; Cizmecioglu 
et al., 2010; Dzhindzhev et al., 2010; Hatch et al., 2010). The 
C-terminal Asl-C region associates with the centriolar outer-
surface protein SAS-4/CPAP, whereas a large central region in 
Cep152 binds Cep192 (Spd-2 in Drosophila and Caenorhab­
ditis elegans). The N-terminal Asl-A region directly binds the 
central tandem Polo Box cassette (PB1-PB2) within Plk4. Asl 
is thought to bind Plk4 and target it to the centriole surface via 
its association with SAS-4/CPAP to initiate procentriole assem-
bly (Dzhindzhev et al., 2010; Cizmecioglu et al., 2010). Thus, 
in Asl-depleted Drosophila cells, Plk4 fails to localize to centri-
oles and centrioles do not duplicate (Dzhindzhev et al., 2010).
Endogenous Plk4 protein is nearly undetectable in cells 
because it efficiently promotes its own destruction (Cunha- 
Ferreira et al., 2013; Klebba et al., 2013). This observation 
raises a perplexing question: if the role of Asl is only to tar-
get Plk4 to centrioles, how does Asl overexpression induce 
centriole amplification? Inspired by this question, we sought 
to identify new Asl functions by performing a comprehensive 
analysis of the interaction between Plk4 and Asl. We have dis-
covered that a second Plk4-binding domain in the Asl C-terminal 
region (Asl-C) is sufficient to induce centriole amplification. 
Furthermore, mechanistic experiments demonstrate that Asl is 
an important regulator of Plk4 levels; Asl-A primarily promotes 
Plk4 dimerization and facilitates its degradation, whereas Asl-C 
stabilizes Plk4 to promote centriole amplification. Collectively, 
Asl possesses two functionally distinct Plk4-binding domains 
with opposing activities and acts not only to shuttle Plk4 to cen-
trioles but forms a stabilizing complex during mitosis to pre-
vent Plk4 degradation.
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Asl (Fig. S1 D), transfecting with inducible Asl-EGFP frag-
ments, and then measuring centriole numbers after an additional 
3 d of expression. (Levels of transgenic proteins are compared 
with endogenous Asl levels in Fig. S1, E and F.) As expected, 
Asl depletion caused significant centriole loss (less than two 
centrioles) compared with controls (Fig. 1 D). Replacement 
with either Asl-A or Asl-B could not rescue this defect. Strik-
ingly, Asl replacement with Asl-BC or Asl-C not only signifi-
cantly rescued centriole loss but also lead to significant 
overduplication (Fig. 1, C and D, last two sets of bars). Thus, 
our findings indicate that Asl-C expression alone is sufficient to 
Consistent with a previous study, expression of FL Asl induced 
centriole amplification (Dzhindzhev et al., 2010) compared with 
controls. Asl-A and Asl-B expression did not have this effect. 
Strikingly, Asl-C expression induced centriole amplification at 
levels similar to FL Asl.
It was surprising that Asl-C expression induced centriole 
amplification because the only known Plk4-binding domain is 
in Asl-A. However, because transgenic Asl binds endogenous 
Asl (Fig. S1 A), Asl-C could amplify centrioles by influencing 
Plk4 through its association with endogenous Asl. Therefore, we 
performed “replacement” experiments by depleting endogenous 
Figure 1. The Asl-C region is sufficient for 
centriole duplication, whereas the Asl-A re-
gion is not. (A) Linear map of the Drosophila 
Asl polypeptide showing functional and struc-
tural domains. Red boxes indicate regions of 
predicted coiled coils (CC). Asl is divided into 
three previously identified scaffolding domains 
(A, B, and C). Asl-A binds Plk4 and Asl-C 
binds SAS-4. (B) Asl fragments oligomerize. 
Three consecutive His6-tagged Asl fragments: 
Asl-A (aa 1–357), Asl-B (aa 358–625), and 
Asl-C (aa 626–994) were analyzed using 
SEC-MALS. Normalized A280 is shown in gray 
(y axis at right), and elution time is indicated 
in minutes (x axis). Calculated MM was de-
termined for each elution peak and is repre-
sented by the dark trace (y axis at left, n = 3 
experiments). Mean molecular masses (±SD) 
for the traces are indicated. Horizontal dashed 
lines indicate the molecular masses of hypo-
thetical monomeric, dimeric, and trimeric spe-
cies for each fragment. (C) Asl-C contains the 
centriole-targeting domain. S2 cells were de-
pleted of endogenous Asl for 3 d using RNAi 
targeting the 5–3UTR and transfected with 
the indicated inducible Asl-EGFP construct. 
While under continuous RNAi treatment, trans-
fected cells were allowed to recover for 24 h, 
induced to express for an additional 24 h, and 
then immunostained for centrioles using the 
anti-PLP antibody. Representative images of 
localization patterns of the Asl fragments are 
shown (n = 100 cells scored/construct). Insets 
show centrioles (yellow boxes) at higher mag-
nification. Bars: (main images) 5 µm; (insets) 
0.5 µm. (D) Replacement of endogenous Asl 
with Asl-BC or Asl-C rescues centriole dupli-
cation and promotes centriole amplification. 
S2 cells were depleted of endogenous Asl using 
the indicated exon-targeting RNAi for 3 d and 
transfected with the indicated inducible Asl-
EGFP construct (or control EGFP). While under 
continuous RNAi treatment, transfected cells 
were allowed to recover for 24 h and induced 
to express for an additional 3 d, and centrioles 
were visualized by anti-PLP immunostaining. 
Each bar shows the mean percentage of cells 
containing the indicated number of centrioles 
(n = 3 experiments; 300 cells counted per 
treatment, per experiment). Asterisks mark sig-
nificant differences (relative to control) for se-
lected comparisons. **, 0.01 > P ≥ 0.001; 
***, P < 0.001. Error bars indicate SEM. Cell 
lysates were immunoblotted to verify expres-
sion of the Asl-EGFP fragments and knockdown 
of endogenous Asl (Fig. S1 D). Cntrl, control.
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of PB1-PB2 abolished the interaction (Fig. 2 D, lanes 7 and 9). 
Therefore, Asl-C binds Plk4 and PB1-PB2 is necessary for this 
interaction. Furthermore, GST pull-down assays showed that, 
similar to Asl-A, Asl-C bound to PB1-PB2 in vitro (Fig. S2, 
E and F).
Lastly, interactions between Asl and Plk4 were examined 
by Y2H, which included both FL proteins, Asl fragments, and 
Plk4 functional domains (Fig. 2 E). As expected, both Asl-FL 
and Asl-A strongly interacted with PB1-PB2 but not with the 
last, C-terminal Plk4 Polo box (PB3). Similarly, Asl-C associ-
ated with Plk4-FL and strongly interacted with PB1-PB2 but not 
PB3. No binding was detected between Asl-B and Plk4. Col-
lectively, our results demonstrate that Asl contains two distinct 
domains at either end of the protein that directly bind Plk4.
The Plk4-binding domain in Asl-C is 
important for centriole duplication
Because an Asl-BC construct can effectively replace endog-
enous Asl and promote centriole duplication, we next asked 
whether the Plk4-binding domain in Asl-C is necessary for this 
function. Using random PCR-based mutagenesis, we generated 
five Asl-C mutants that fail to interact with PB1-PB2 but that 
still bind Asl-B (Fig. S3 A). One of these mutants, J11F10 con-
taining three missense mutations (E698G, E789D, and S906P), 
was chosen for further characterization. The J11F10 mutations 
specifically blocked the interaction of Asl with Plk4 but did 
not interfere with its binding to SAS-4 (Fig. S3 A). Moreover, 
we examined its ability to interact with Spd-2 because Cep152 
binds Cep192 (the human orthologues of Asl and Spd-2, respec-
tively; Sonnen et al., 2013). We found that Asl-C also strongly 
interacts with the C-terminal half of Spd-2 (Fig. S3 A) and that 
the J11F10 point mutations do not inhibit this association 
(Fig. S3 A). In addition, the J11F10 mutations do not prevent cen-
triole targeting because a construct of EGFP–Asl-BC containing 
the J11F10 mutations still localized to centrioles (Fig. S3 B).
Lastly, recent work in human cells has shown that Plk4 
PB1-PB2 also binds Cep192, which cooperates with Cep152 to 
target Plk4 to centrioles (Kim et al., 2013; Sonnen et al., 2013). 
Using a Y2H assay, we found that Spd-2 did not interact with 
any fly Plk4 domain (Fig. S3 C). The absence of a Plk4–Spd-2 
interaction potentially explains why Plk4 does not localize to 
centrioles in Asl-depleted Drosophila cells, unlike the situa-
tion in Cep152-depleted human cells (Cizmecioglu et al., 2010; 
Dzhindzhev et al., 2010; Hatch et al., 2010). Thus, Plk4 target-
ing to centrioles in fly cells appears to be exclusively mediated 
by two Plk4 binding sites in Asl but not by Spd-2.
We now tested the functional importance of the Plk4-binding 
domain within Asl-C by performing replacement experiments 
using an Asl-C construct unable to bind Plk4. Specifically, cen-
trioles were counted in cells depleted of endogenous Asl and 
expressing either wild-type (WT) or J11F10-mutated Asl-BC. 
As before, centriole number was significantly decreased after 
Asl depletion, and this phenotype was rescued by expression of 
EGFP–Asl-BC (Fig. S3 D). However, expression of EGFP– 
Asl-BC containing the J11F10 mutations failed to rescue centri-
ole duplication (Fig. S3 D). Thus, the Plk4-binding activity within 
Asl-C is necessary and sufficient for centriole duplication.
rescue centriole duplication and induce centriole amplifica-
tion in Asl-depleted cells. Moreover, Asl-A is expendable with 
regard to centriole duplication, a remarkable result given that 
Asl-A contains the known Plk4-binding domain thought to posi-
tion Plk4 at centrioles (Dzhindzhev et al., 2010).
Asl stabilizes Plk4 through Asl-C
Given these results, we hypothesized that Asl possesses multi-
ple mechanisms to regulate Plk4 activity. Possibly, Asl not only 
shuttles Plk4 to centrioles but also stabilizes Plk4 by suppress-
ing its degradation. To test these hypotheses, we expressed Plk4-
EGFP with either FL Asl or the Asl fragments and analyzed 
Plk4 levels. As expected, Plk4-EGFP was not easily detectable 
as a result of its ability to autodestruct (Fig. 2 A, lane 1). How-
ever, coexpression with Asl-FL resulted in a marked rise in Plk4 
level as well as an upward shift in its electrophoretic mobility 
(Fig. 2 A, lane 2). This stabilizing effect was not caused simply 
by an increase in centrioles, as Plk4-EGFP stability was also 
observed in Asl-FL-V5–expressing cells that were depleted of 
the essential centriole protein SAS-6 (Fig. 2 B, lane 4), which 
efficiently reduced centriole numbers in these cells (Fig. S2 B). 
The reduced electrophoretic mobility of Plk4 raises the inter-
esting possibility that Asl stabilizes Plk4 in a phosphorylated 
state, perhaps by stimulating Plk4 autophosphorylation. In-
deed,  phosphatase treatment of Plk4 immunoprecipitated 
from cells coexpressing Asl shifted Plk4 to faster migrating 
species, suggesting that Asl may promote Plk4 autophosphoryla-
tion (Fig. S2 C). Coexpression of Asl-A or Asl-B did not alter 
Plk4 levels (Fig. 2 A, lanes 3 and 4). To eliminate the possibility 
that endogenous Asl is necessary for Asl-C to stabilize Plk4, we 
depleted endogenous Asl in cells expressing Plk4-EGFP alone 
or Plk4-EGFP with Asl-C. Asl-C significantly stabilized Plk4 
in the presence or absence of endogenous Asl relative to Plk4 
expression alone (Fig. S2 D). These findings demonstrate a new 
role for Asl in stabilizing Plk4 and provide a mechanism ex-
plaining how Asl expression promotes centriole amplification. 
Moreover, Asl-C is largely responsible for this activity.
Asl contains a second Plk4-binding  
domain in Asl-C
Our finding that Asl-C stabilizes Plk4 and induces centriole am-
plification suggests that Asl contains a previously unidentified 
Plk4-binding domain in the C-terminal region. First, we tested 
whether Plk4 stabilization requires direct interaction with Asl 
by coexpressing Asl with a Plk4 mutant lacking the critical Asl-
binding domain, Polo boxes 1 and 2 (Plk4-PB1-PB2-EGFP). 
Asl expression had no effect on the level of the PB1-PB2 mu-
tant (Fig. 2 C). Therefore, the Plk4 Asl-binding domain (PB1-
PB2) is required for Asl to stabilize Plk4, suggesting that Asl 
directly interacts with Plk4.
To test whether Asl-C binds PB1-PB2, we used immuno-
precipitations, in vitro protein binding assays, and Y2H analysis. 
S2 cells depleted of endogenous Asl were induced to express 
Asl-C alone or Asl-C plus either control EGFP or different Plk4- 
EGFP constructs (Fig. 2 D). Western blots of the immuno-
precipitated GFP-tagged proteins (Fig. 2 D, lanes 5 and 7) 
demonstrated that Asl-C readily bound FL Plk4, whereas deletion 
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N-terminal region. In order for centriole duplication to occur 
properly, Asl requires the C-terminal Plk4-binding domain.
Asl stabilizes Plk4 by aggregation and 
suppresses Plk4 turnover
Our results demonstrate that Asl stabilizes Plk4 but the mecha-
nism is unclear. One possibility is that Asl binding to PB1-PB2 
To test whether the two Plk4 binding sites of Asl are func-
tionally redundant, we expressed WT or J11F10-mutated FL 
Asl in cells that had been depleted of endogenous Asl. As ex-
pected, Asl-FL-WT expression rescued centriole loss, but Asl-
FL-J11F10 expression did not (Fig. 3 A). Thus, to the extent 
demonstrable by this assay, the Plk4-binding activity within the 
Asl C-terminal region is not redundant to the activity within the 
Figure 2. Asl contains a second Plk4 PB1-PB2–binding domain in its C terminus that is sufficient for stabilizing Plk4. (A) Asl stabilizes Plk4 primarily 
through its C terminus. The relative stability of Plk4-EGFP protein was analyzed by immunoblotting lysates of S2 cells transiently coexpressing the indicated 
inducible Asl-V5 constructs. Cotransfected Nlp-EGFP was expressed under its endogenous promoter and served as a loading control. Blots were probed 
with anti-GFP, V5, and Asl. In lane 2, FL Asl-V5 and endogenous (Endo) Asl are not resolvable, so the band contains both species. (B) Asl stabilizes Plk4 
in cells lacking centrioles. S2 cells were control or SAS-6 RNAi treated for 6 d. On day 4, cells were transfected with inducible Plk4-EGFP alone or with 
Asl-V5 and then induced to express the next day for 24 h. Proteins were detected by immunoblotting cell lysates with anti-GFP, V5, and SAS-6 antibodies. 
Cotransfected Nlp-EGFP was used as a loading control. Con, control. (C) Asl stabilization of Plk4 requires PB1-PB2. The relative protein stability of a Plk4-
EGFP mutant lacking PB1-PB2 was analyzed by immunoblotting lysates of S2 cells that were or were not transiently coexpressing Asl-V5. Cotransfected 
Nlp-EGFP was used as a loading control. (D) PB1-PB2 is necessary for Plk4 to associate with Asl-C. S2 cells were control or Asl 5–3UTR RNAi treated for 
7 d. On day 5, cells were cotransfected with inducible Asl-C–V5 and the indicated inducible Plk4-EGFP construct (or control EGFP) and induced to express 
the next day for 24 h, and then lysates were prepared for anti-GFP immunoprecipitation. Immunoblots were probed for V5, GFP, and endogenous Asl. IP, 
immunoprecipitation. (E) Asl-A and Asl-C interact specifically with PB1-PB2 in Plk4 by Y2H analysis. FL and fragments of Asl and Plk4 were screened by 
Y2H. In each image, colonies from replica plating are shown. (left image) Growth indicates the presence of both bait and prey. (right image) Growth on 
DDOXA, and color indicates an interaction. AA indicates that one or both protein fragments autoactivated the Y2H reporters on their own and could not 
be tested. Both Asl-A and Asl-C strongly interacted with PB1-PB2 but not PB3. KinDom, kinase domain.
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(Fig. 3 B, lane 2, IP). Thus, Asl does not inhibit Slimb-mediated 
ubiquitination of Plk4. Moreover, the association with Slimb 
suggests that stabilized Plk4 is catalytically active, capable of 
trans-autophosphorylating to recruit Slimb.
Transiently expressed Plk4-EGFP is normally observed at 
centrioles (Fig. 3 C). However, when Asl is coexpressed with 
Plk4, cells contained large aggregates of both proteins and PLP 
(Fig. 3 C). Indeed, 80% of coexpressing cells contained Plk4 
could prevent recognition by the SCFSlimb Ubi ligase and, thus, 
ubiquitination of Plk4. To test this, we expressed Plk4-EGFP 
with Asl-V5 in cells cotransfected with 3×FLAG-Ubi. As 
shown previously (Rogers et al., 2009), immunoprecipitation of 
Plk4 retrieves endogenous Slimb, and Plk4 is robustly labeled 
with FLAG-Ubi (Fig. 3 B, lane 1). Coexpression with Asl dra-
matically increased Plk4 protein levels (Fig. 3 B, lane 2, input) 
but, surprisingly, did not affect Slimb binding or ubiquitination 
Figure 3. Asl stabilizes Plk4 in aggregates 
with supernumerary centrioles. (A) Disruption 
of the C-terminal Plk4-binding domain with the 
J11F10 mutation compromises centriole dupli-
cation. S2 cells were transfected with inducible 
EGFP-FL-Asl, J11F10 mutant, or EGFP and ei-
ther control or Asl depleted using Asl UTR RNAi 
for 6 d. Cells were anti-PLP immunostained, and 
centriole numbers were measured. Each bar 
shows the mean percentage of cells contain-
ing the indicated number of centrioles (n = 5 
experiments; 200 cells counted per treatment, 
per experiment). Asterisks mark significant dif-
ferences between treatments. ***, P < 0.001. 
Error bars indicate SEM. Cntrl, control. (B) Asl 
stabilizes Plk4 but does not prevent its ubiqui-
tination. Anti-GFP immunoprecipitates (IPs) were 
prepared from lysates of S2 cells transiently co- 
overexpressing Plk4-EGFP and 3×FLAG-ubiquitin 
(Ubi) and either with or without Asl-V5. Volumes 
of the IPs were adjusted to load an equivalent 
amount of Plk4 for each immunoblot. Blots were 
probed for -tubulin, GFP, V5, and Asl. Endo, 
endogenous. (C) Plk4-EGFP forms aggregates 
with Asl or Asl-C that recruit PLP. S2 cells were 
transfected with inducible Plk4-EGFP either 
alone, with Asl-V5, or with Asl-C–V5, and then 
induced to express the next day for 24 h. Cells 
were immunostained for PLP. Bar, 5 µm. (D) S2 
cell coexpressing Plk4-EGFP and Asl-V5 was im-
munostained for PLP to mark centrioles. Coex-
pressing Nlp-EGFP (a nuclear protein) was used 
to identify transfected cells. Bar, 2.5 µm. (E–E) 
An S2 cell coexpressing Plk4-EGFP and Asl-V5 
(white in E) was imaged using superresolution 
microscopy. Cells were immunostained for V5 
to mark Asl-V5. (E and E) Higher magnifica-
tions of yellow boxed regions show PLP-labeled 
centrioles (indicated with yellow arrowheads) 
and ring-like Asl and Plk4 structures.
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induced overnight, and then, cycloheximide (CHX) was intro-
duced to block further protein synthesis. Plk4 protein levels were 
then assayed every 2 h (Fig. 4 A). Plk4 is relatively short lived: 50% 
of Plk4 was eliminated <2 h after CHX addition, and only 20% 
remained at the 6 h time point (Fig. 4 B). Protein levels of the con-
trol (nondegradable Plk4–Slimb-binding mutant [SBM]–EGFP) 
were constant throughout the time course (Fig. 4, A and B). Strik-
ingly, coexpression of Asl-FL significantly stabilized Plk4. By 6 h 
after CHX addition, 80% of the Plk4 protein remained. To de-
termine which Asl region decreased Plk4 turnover, we repeated 
the assay with the three Asl fragments (Fig. 4 A). Whereas Asl-A 
and Asl-B did not affect the kinetics of Plk4 degradation, Asl-C 
expression significantly slowed Plk4 turnover rate but not nearly 
as dramatically as Asl-FL (Fig. 4 B). Neither Asl-A nor Asl-C 
were nearly as efficient as Asl-FL in stabilizing Plk4, suggest-
ing that Asl-C has a role in forming an Asl–Plk4 stabilizing com-
plex but that the Plk4 binding site within Asl-A may work 
together with Asl-C for maximal suppression of Plk4 turnover. To 
test this, we coexpressed both Asl-A and Asl-C together with 
Plk4. The two fragments suppressed Plk4 turnover to a similar ex-
tent as Asl-FL (Fig. 4, A and B). Thus, Asl-A and Asl-C act synergis-
tically to stabilize Plk4 without residing on the same polypeptide.
aggregates with PLP (Fig. S3 E). Aggregates were not simply 
the result of Plk4 overabundance because expression of stable, 
nondegradable Plk4 did not generate such aggregates (Klebba 
et al., 2013). Moreover, Asl-C, which is sufficient to stabilize 
Plk4 (Fig. 2 A), also induced formation of identical Plk4 ag-
gregates (Fig. 3 C). Notably, these complexes contained nu-
merous PLP spots (Fig. 3 D). Although both Plk4 and Asl form 
a partially overlapping ring–link network within the aggregate, 
Asl also concentrates at the periphery of the structure (Fig. 3 E). 
We note that centrioles in cells with Asl–Plk4 aggregates display 
distorted PLP structures (Fig. S4, A and B). Possibly, Plk4–Asl 
aggregates act as sinks for centriolar proteins, reducing their 
availability and promoting defects in centriolar structure. There-
fore, coexpression of Asl and Plk4 promotes the formation of 
complexes containing centriolar proteins and, at least in the case 
of Plk4, can stabilize the ubiquitinated protein. Though we 
acknowledge that these aggregates are not physiological, the ar-
rangement of Asl as a shell enclosing a bulk of Plk4 suggests 
that Asl has the ability to sequester Plk4 into a stable complex.
If the Asl–Plk4 complexes protect Plk4 from proteasome-
mediated degradation, this might explain the observed accumula-
tion of Plk4 (Fig. 2 A). To test this, Plk4-EGFP expression was 
Figure 4. FL Asl or Asl-C suppresses Plk4 turnover. (A) S2 cells cotransfected with Plk4-EGFP or nondegradable Plk4 Slimb-binding mutant (SBM) and 
the indicated Asl-V5 constructs were induced to express for 24 h and then treated with fresh media and cycloheximide (CHX) to inhibit protein translation. 
Immunoblots of cell lysates were probed for GFP and V5. Plk4-EGFP protein turnover over a 6-h time course was analyzed by densitometry of the anti-GFP 
immunoblots. (Cotransfected Nlp-EGFP was used as a loading control.) (B) Graphs show relative Plk4-EGFP levels for each treatment normalized against 
Nlp-EGFP over the 6-h time course for three experiments. Error bars show SEM. Expression of Asl-V5 or Asl-C–V5 suppresses Plk4-EGFP degradation. 
Asterisks indicate significant differences between a treatment and the WT control at 6 h. *, 0.05 > P ≥ 0.01; **, 0.01 > P ≥ 0.001; ***, P < 0.001; NS, 
not significant. a.u., arbitrary unit.
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Figure 5. Asl functions to promote Plk4 dimerization and autophosphorylation. (A) Asl increases the phosphorylation state of Plk4. S2 cells were control 
or Asl depleted for 5 d. On day 3, cells were transfected with Plk4-EGFP, and the next day, they were induced to express for 24 h. Immunoblots of cell 
lysates were probed for Asl and GFP. Cotransfected Nlp-EGFP was used as a loading control. Asl depletion increases the proportion of Plk4-EGFP with 
higher electrophoretic mobility (arrow), indicating decreased Plk4 phosphorylation. The graph shows relative amounts of Plk4-EGFP as determined by den-
sitometry of the anti-GFP immunoblots, normalized to Nlp-EGFP, and plotted relative to control (lane 1). n = 6 experiments. (B) Plk4 turnover is suppressed 
in the absence of Asl. S2 cells were control or Asl depleted for 7 d. On day 5, cells were cotransfected with Plk4-EGFP and Nlp-EGFP (loading control) 
and induced the next day to express for 24 h. Cycloheximide (CHX) treatment was performed as indicated in the schematic and as described in Fig. 4 A. 
Immunoblots of cell lysates were probed for GFP and Asl. Plk4-EGFP protein levels were analyzed by densitometry of the anti-GFP immunoblots. Graphs 
show relative Plk4-EGFP levels for each treatment normalized against Nlp-EGFP for two experiments. (C) The impact of Asl on Plk4 autophosphorylation and 
Slimb binding can be masked by high levels of Plk4 expression. S2 cells were control or Asl-RNAi treated for 7 d. On day 5, cells were transfected with 
Plk4-EGFP, and the next day, they were induced to express using three different concentrations of CuSO4 for 24 h. Anti-GFP immunoprecipitates (IPs) were 
then prepared from lysates, and immunoblots were probed for GFP, Slimb, Asl, and -tubulin. Graph shows relative amounts of Slimb as determined by 
densitometry of the anti-Slimb immunoblots, normalized to Plk4-EGFP. Data shown are from a single representative experiment (n = 2 independent experi-
ments). (D) Asl increases Plk4 dimerization. Anti-GFP immunoprecipitates were prepared from lysates of S2 cells transiently coexpressing Plk4-EGFP and 
Plk4-myc and with or without Asl-V5. Blots of the input lysates and immunoprecipitates were probed for -tubulin, GFP, V5, Asl, and myc. The graph shows 
relative amounts of Plk4-myc bound to Plk4-EGFP. For each treatment, levels of tagged Plk4 in the immunoprecipitates were determined by densitometry 
of the anti-GFP and myc immunoblots, normalized to measure Plk4-EGFP, and then plotted relative to control (lane 1). Asterisks mark significant difference 
compared with control. *, 0.05 > P ≥ 0.01. n = 3–4 experiments per treatment. Error bars indicate SEM. a.u., arbitrary unit; Con, control; Tub, tubulin.
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Asl promotes Plk4 autophosphorylation
Because Asl expression stabilizes Plk4, we predicted that Asl 
depletion would decrease Plk4 protein levels. Surprisingly, Asl 
depletion doubled Plk4 levels (Figs. 5 A and S2 D). The explana-
tion for this unexpected result may lie in the change of Plk4’s 
electrophoretic mobility after Asl depletion. Plk4 normally runs 
as a multibanded smear on SDS-PAGE (Fig. 5 A, lane 1) but col-
lapses to a single band if mutated to kinase dead (Klebba et al., 
2013) or if treated with a phosphatase (Fig. S2 C). Therefore, 
the multiple bands likely correspond to multiple phosphoryla-
tion states. Depletion of Asl altered the electrophoretic mobility 
of Plk4, increasing the proportion of Plk4 present in a focused, 
fast-migrating band, which likely corresponds to a low- or non-
phosphorylated isoform (Fig. 5 A, lane 2, arrow). Since previous 
studies have shown that Plk4 phosphorylation is a prerequisite 
for Slimb-mediated degradation (Cunha-Ferreira et al., 2009; 
Rogers et al., 2009), it follows that Plk4 levels would increase 
if its autophosphorylation is suppressed by Asl depletion.
The previous result was further supported by measuring 
Plk4 turnover in Asl-depleted cells. Compared with controls, 
Asl depletion significantly slowed Plk4 turnover (P = 0.0236 at 
6 h), increasing Plk4 stability (Fig. 5 B). Strikingly, not all of 
the Plk4-phosphorylated isoforms are equally stabilized by Asl 
depletion: the low-phosphorylated Plk4 isoform preferentially 
accumulated in the absence of Asl. Thus, Asl normally increases 
Plk4 turnover, probably by facilitating its phosphorylation.
Asl facilitates Plk4 homodimerization
Homodimers of Plk4 trans-autophosphorylate to generate a 
Slimb-binding phosphodegron, thereby promoting its own de-
struction (Holland et al., 2010; Guderian et al., 2010; Cunha-
Ferreira et al., 2013; Klebba et al., 2013). Our findings suggest that 
Asl increases Plk4 autophosphorylation and degradation. In con-
trast, previous studies found that Asl does not regulate Plk4 levels 
(Cizmecioglu et al., 2010; Dzhindzhev et al., 2010). However, it 
is possible that high levels of exogenous Plk4 expression might 
have obscured the effect of Asl on Plk4 regulation. To test this, 
we induced Plk4-EGFP expression at a range of concentrations 
in control and Asl-depleted S2 cells (Fig. 5 C). Plk4-EGFP pro-
tein was immunoprecipitated from cell lysates, and quantitative 
immunoblotting was used to measure the amount of associated 
Slimb, which only binds trans-autophosphorylated Plk4 (Guderian 
et al., 2010; Cunha-Ferreira et al., 2013; Klebba et al., 2013). At 
low expression, Plk4 was nearly undetectable in control lysates 
(Fig. 5 C, lane 1, Input) but readily pulled down Slimb (Fig. 5 C, 
lane 1, IP). However, at the same level of induction, Slimb binding 
was sharply decreased (and Plk4 protein in the lysate increased) 
by depletion of Asl (Fig. 5 C, lane 2). Increasing Plk4 expression 
moderately (Fig. 5 C, lanes 3 and 4) or to higher levels (Fig. 5 C, 
lanes 5 and 6) diminished the effect of Asl on Plk4 autophos-
phorylation (as indicated by the increasing levels of bound Slimb 
in Asl-depleted cells). Thus, at low Plk4 levels, Asl plays an impor-
tant role in facilitating the Plk4–Slimb interaction, revealing a new 
layer of complexity to Plk4 regulation and Asl function in cells.
Plk4 homodimerization is mediated by interactions between 
the PB1-PB2 domains (Slevin et al., 2012), which also bind Asl. 
We hypothesized that Asl facilitates Plk4 autophosphorylation 
by interacting with multiple Plk4 monomers, thus increasing the 
probability of dimerization. Alternatively, Asl may stabilize ex-
isting dimers, thereby promoting Plk4 trans-autophosphorylation 
and degradation. To test the effect of Asl on Plk4 dimerization, we 
coexpressed Plk4-EGFP and Plk4-myc in S2 cells and measured 
the amount of Plk4-myc in the anti-GFP immunoprecipitate. 
As expected, Plk4-myc binds Plk4-EGFP and is readily recov-
ered (Fig. 5 D, lane 1). However, coexpression of Asl in these 
cells significantly increased the amount of bound Plk4-myc by 
approximately fourfold (Fig. 5 D, lane 2). To eliminate the pos-
sibility that the increased dimerization was simply a result of 
increased Plk4 levels as a result of Asl expression, we performed 
the same assay using nondegradable (SBM) Plk4 mutants. 
A modest increase in dimerization was obtained with Plk4-SBM 
(Fig. 5 D, lanes 3 and 4), likely because high Plk4 levels are not 
as reliant on Asl for dimerization (Fig. 5 C). Thus, these results 
support the hypothesis that Asl stabilizes Plk4 dimers.
Asl-A promotes Plk4 homodimerization  
and autophosphorylation
To identify which Asl region increases Plk4 dimerization, we 
performed dimerization assays using Asl fragments or Asl-FL. 
Expression of Asl-A significantly increased dimerization, as did 
Asl-FL expression (Fig. 6 A, lanes 2 and 3). Expression of ei-
ther Asl-B or Asl-C did not affect Plk4 dimerization (Fig. 6 A, 
lanes 4 and 5). Therefore, Asl-A increases Plk4 dimerization.
If Asl-A promotes Plk4 dimerization, this predicts that it 
should also promote Plk4 autophosphorylation. We tested whether 
Asl-A is sufficient to induce Plk4 trans-autophosphorylation 
using Slimb binding as a readout for Plk4 autophosphorylation 
in cells. Asl levels were depleted in S2 cells followed by Plk4-
EGFP expression with or without Asl-A. (Induction was moder-
ated to generate an expressed Plk4-EGFP level that requires Asl 
for efficient Slimb recruitment; Fig. 5 C, lanes 1 and 2.) Plk4-
EGFP was then immunoprecipitated from cell lysates and probed 
for associated Slimb. Asl-A did not alter the amount of Slimb 
bound to Plk4-EGFP in control cells containing endogenous Asl 
(Fig. 6 B, lanes 1 and 2), inferring that Plk4 autophosphorylation 
was unchanged. However, when the same assay was performed 
in a background of depleted endogenous Asl, the decrease in 
Slimb binding that resulted from Asl depletion was rescued by 
Asl-A (Fig. 6 B, lanes 3 and 4). These findings suggest that Asl-A 
promotes Plk4 dimerization and autophosphorylation.
Asl is required to stabilize Plk4  
during mitosis
Thus far, our results indicate that Asl contains two separate 
Plk4-binding domains that exert opposite influences on Plk4 
stability. Whereas Asl-C decreases Plk4 turnover, Asl-A facili-
tates Plk4 dimerization, autophosphorylation, and Slimb bind-
ing. These opposing Asl activities could function differentially 
throughout the cell cycle. Asl-A activity could predominate 
during interphase to stimulate Plk4 degradation, whereas Asl-C 
activity might stabilize Plk4 during mitosis (Fode et al., 1996; 
Rogers et al., 2009). To test whether Asl stabilizes mitotic Plk4, 
we examined Plk4-EGFP levels in asynchronous (i.e., almost 
entirely interphase) and mitotic cells that were either Asl depleted 
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the Asl/Cep152 N terminus (Asl-A) binds Plk4 on its central 
tandem Polo Box cassette (PB1-PB2) and shuttles it to centri-
oles to promote centriole duplication (Cizmecioglu et al., 2010; 
Dzhindzhev et al., 2010; Hatch et al., 2010). In human cells, 
Plk4 targeting is more complex because Cep152 cooperates with 
Cep192 in this function (Kim et al., 2013; Sonnen et al., 2013). 
Plk4 targeting to centrioles appears to be simpler in Drosophila. 
We found that Plk4 does not interact with the Cep192 orthologue, 
Spd-2, and so its targeting relies primarily on Asl. Surprisingly, 
removal of the Asl-A region, which contains the previously char-
acterized Plk4 binding domain, did not prevent centriole over-
duplication by overexpressed Asl. This is caused by a second 
Plk4-binding domain in the Asl C terminus (Asl-C), which also 
associates with SAS-4 and Spd-2, localizes to centrioles, and is 
sufficient for their overduplication when overexpressed. It would 
be intriguing to know whether Cep152 also contains a second 
or control treated. Plk4-EGFP–expressing cells were arrested 
in mitosis either by depletion of Fizzy (Pesin and Orr-Weaver, 
2008) or by treatment with colchicine. Although both treatments 
only elevated the mitotic index to 25%, Plk4-EGFP levels were 
markedly increased in mitotic cells as compared with asynchro-
nous culture and were shifted to a higher phosphorylated form 
(Fig. 6 C), as previously described (Brownlee et al., 2011). Strik-
ingly, Asl depletion decreased Plk4 levels and reduced apparent 
phosphorylation levels of Plk4. Thus, our findings reveal a new 
role for Asl in stabilizing Plk4 during mitosis.
Discussion
Our investigations of the interactions between the conserved 
proteins Asl and Plk4 have revealed new features of this 
centriole-assembly complex. Previous studies have shown that 
Figure 6. Asl-A is sufficient to promote Plk4 dimerization and autophosphorylation, and Asl is required for stabilizing Plk4 during mitosis. (A) Asl-A is suf-
ficient to induce Plk4 dimerization. Anti-GFP immunoprecipitates (IPs) were prepared from lysates of S2 cells transiently coexpressing Plk4-EGFP, Plk4-myc, 
and full-length (FL) Asl-V5 or the indicated Asl-V5 fragment. Blots of the input lysates and IPs were probed for -tubulin, GFP, V5, Asl, and myc. The graph 
shows relative amounts of Plk4-myc bound to Plk4-EGFP. For each treatment, levels of tagged Plk4 in the IPs were determined by densitometry of the anti-GFP 
and myc immunoblot and then normalized to measure Plk4-EGFP, and the results were plotted relative to control (lane 1). Asterisks mark significant differ-
ences compared with control. *, 0.05 > P ≥ 0.01. n = 2–4 experiments per treatment. Error bars indicate SEM. Endo, endogenous. (B) Asl-A is sufficient 
to facilitate Plk4 autophosphorylation and Slimb binding in the absence of endogenous Asl. S2 cells were control or Asl depleted for 7 d. On day 5, cells 
were transfected with Plk4-EGFP with or without Asl-A–V5, and the next day, they were induced to express for 24 h. Anti-GFP immunoprecipitates were then 
prepared from lysates, and immunoblots of the inputs and IPs were probed for GFP, Slimb, Asl, V5, and -tubulin. (C) Asl is required for stabilizing Plk4 
levels during mitosis. S2 cells were arrested in mitosis by Fizzy (Fzy) depletion (left) or 24 h of colchicine (Colch) treatment (right). Cells were control, Asl, 
Fizzy, or Fizzy/Asl RNAi treated for 6 d. On day 4, cells were transfected with Plk4-EGFP and Nlp-GFP (loading control) and induced to express for 24 h 
the next day. Cells were treated with colchicine on day 6. Immunoblots of cell lysates were probed for Asl, Fzy, and GFP. Con, control.
411Asterless crosslinks and stabilizes Plk4 • Klebba et al.
et al., 2007; Rogers et al., 2009). Previously, we have shown that in 
Drosophila PP2A, in complex with its regulatory subunit Twins, 
counteracts Plk4 autophosphorylation of the Slimb-binding do-
main to promote Plk4 stabilization during mitosis (Brownlee 
et al., 2011). Remarkably, the impact of Asl on Plk4 switches 
during mitosis, and Asl stabilizes mitotic Plk4. An important goal 
will be to understand the cell cycle–dependent changes in Asl 
that regulate its ability to either stabilize Plk4 or facilitate its deg-
radation. Possibly, Asl and PP2ATwins collaborate in a functional 
complex to promote mitotic Plk4 stability. Notably, the N terminus 
of Cep152 is also a Plk4 substrate (Hatch et al., 2010), and, when 
Plk4 levels rise during mitosis, it may phosphorylate Asl to mod-
ulate this region’s Plk4 stabilization activity. Future studies will 
be necessary to determine the physiological significance of Asl 
as a Plk4 substrate.
Lastly, our analysis suggests that Asl forms a complex 
oligomer with Asl-A and -B regions each homodimerizing and 
Asl-C forming a homotrimer. Likely, Asl molecules form par-
allel coiled coils as their N and C termini spatially map to dis-
tinct, independent locations on the centriole surface (Mennella 
et al., 2012). Based on its ability to both dimerize and trimer-
ize, we propose that Asl may exist as a homohexamer, capa-
ble of forming higher-order structures that could be enhanced 
with Plk4 binding (Fig. 7). Accordingly, during interphase, 
Asl-A dimers bind and promote/maintain Plk4 homodimer 
status, thereby facilitating Plk4 trans-autophosphorylation 
and Slimb recruitment. During mitosis, Plk4 is stabilized by 
PP2ATwins and shuttled to the centriole via Asl where it may be 
transferred to multiple Asl-C regions, thereby cross-linking the 
kinase into a stable complex. Interestingly, Asl-C expression 
alone does not stabilize Plk4 to the same extent as FL Asl. In 
fact, expression of Asl-A and Asl-C work synergistically to sup-
press Plk4 turnover.
It is tempting to speculate that the asymmetric Plk4 spot 
on mitotic centrioles consists of an organized higher-order 
Plk4 binding site. If not, then perhaps the multiple functions of 
Asl have been divided between Cep152 and Cep192, with Cep192 
performing the functions allocated to Asl-C.
Asl overexpression induces centriole amplification 
(Dzhindzhev et al., 2010; Stevens et al., 2010). Our experiments 
have revealed several new properties of Asl that better explain 
the control Asl exerts on centriole numbers. Structurally it ap-
pears that different regions of Asl collaborate when interacting 
with Plk4. Our experiments indicate that Asl-C and -B bind, sug-
gesting that Asl adopts a folded conformation with potential im-
portant functional consequences. Future studies should be aimed 
at solving the atomic structure of Asl in complex with PB1-PB2 
to determine whether Asl-A and Asl-C compete for the same 
binding site in Plk4 as observed with Cep152 and Cep192. In-
triguingly, Asl expression does not prevent Plk4 ubiquitination. 
Although it is not clear how Plk4 escapes proteasomal degra-
dation, it is possible that formation of higher-order Asl–Plk4 
complexes hinder Plk4 shuttling to proteasomes. Indeed, Plk4 
and Asl form aggregates in cells, which recruit PLP. At present, 
it is not known whether these Plk4–Asl aggregates sequester 
Plk4 and suppress its turnover or whether aggregation is simply 
a consequence of Plk4 stabilization.
This study highlights an odd functional duality of Asl. 
Although Asl overexpression induces centriole amplification 
by stabilizing Plk4, Asl depletion does not have the opposite 
effect in asynchronous cells but, instead, increases the levels of 
a low or nonphosphorylated Plk4 species. We found that Asl-A 
binds and promotes Plk4 dimerization, thereby facilitating its au-
tophosphorylation and recruitment of Slimb. These opposing Asl 
activities are likely cell cycle dependent. Most of our experiments 
examined Asl activity during interphase, when Asl primarily as-
sists in promoting Plk4 dimerization and degradation. However, 
during mitosis, Plk4 protein levels rise, and it decorates centri-
oles as an asymmetric spot where it has been proposed to act 
as a platform to initiate centriole duplication (Rodrigues-Martins 
Figure 7. Model of Plk4 turnover regulation 
by domain-specific and cell cycle–dependent 
activities of Asl. (top) A cytoplasmic Asl–Plk4 
complex forms during interphase to facilitate 
Plk4 degradation. Asl-A binding to Plk4 is domi-
nant and facilitates Plk4 homodimerization 
and autophosphorylation, triggering its ubiqui-
tination by SCFSlimb and degradation. (bottom) 
A centriolar Asl–Plk4 complex forms during 
mitosis to stabilize Plk4 and initiate centriole 
duplication. PP2ATwins counteracts Plk4 auto-
phosphorylation, allowing Plk4 protein levels 
to rise. Asl-C trimers bind Plk4 dimers, form-
ing high-order structures that protect Plk4 from 
proteasome-mediated degradation. Asl-A also 
participates in stabilizing mitotic Plk4, but the 
mechanism by which this occurs is unclear. Plk4 
aggregates into an asymmetric spot on the cen-
triole surface, which modifies the centriole, mak-
ing it competent to assemble a single daughter 
during S phase. P, phosphorylation.
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Immunoblotting
S2 cell extracts were produced by lysing cells in cold PBS and 0.1% Triton 
X-100. Laemmli sample buffer was then added and boiled for 5 min. 
Samples of equal total protein were resolved by SDS-PAGE, blotted, 
probed with primary and secondary antibodies, and scanned on an Odyssey 
imager (LI-COR Biosciences). Care was taken to avoid saturating the scans 
of blots. Transfected Nlp-EGFP (a constitutively expressed nuclear pro-
tein; Rogers et al., 2009) was used as a loading control and transfection 
marker. Antibodies used for Western blotting include guinea pig anti-Slimb 
(Brownlee et al., 2011), guinea pig anti–SAS-6 (Rogers laboratory), rabbit 
anti-Fizzy (Rogers laboratory), guinea pig anti-Asl (Klebba et al., 2013), 
mouse anti-V5 monoclonal (Life Technologies), mouse anti-GFP monoclonal 
JL8 (Takara Bio Inc.), mouse anti-myc (Cell Signaling Technology), mouse 
anti–-tubulin monoclonal DM1A (Sigma-Aldrich), and mouse anti-FLAG 
monoclonal (Sigma-Aldrich) used at 1:1,000 dilutions. IRDye 800CW sec-
ondary antibodies (LI-COR Biosciences) were prepared according to the 
manufacturer’s instructions and used at 1:1,500 dilutions.
Constructs and transfection
FL cDNAs of Drosophila Asl and Plk4 were subcloned into a pMT vector 
containing in-frame coding sequence for EGFP, V5, or myc and the induc-
ible metallothionein promoter. Phusion polymerase (Thermo Fisher Scien-
tific) was used according to manufacturer’s instructions to generate the 
various Asl and Plk4 deletion and point mutants. Transient transfections 
of S2 cells were performed using a Nucleofector II and Nucleofector kit 
V (Lonza) according to manufacturer’s instructions. In most experiments, 
1.8 µg of Asl or Plk4 expression plasmid was mixed with 0.2 µg of Nlp-
EGFP expression plasmid to either identify transfected cells or to serve as 
a loading control. Expression of all Plk4 constructs (and GFP control) was 
induced by the addition of 50 µM–2 mM copper sulfate to the culture 
medium. Colchicine and CHX (Sigma-Aldrich) were used at final concen-
trations of 30 and 100 µM, respectively.
Protein binding assays
Asl fragments (A, aa 1–357; B, aa 358–625; and C, aa 626–994) 
were PCR amplified from a FL Asl cDNA, and directionally subcloned into 
pET28b (Life Technologies) using BamHI and EcoRI restriction enzymes (Pro-
mega) to generate N-terminal His6-tagged constructs. The PB1-PB2 domain 
was PCR amplified from a Plk4 cDNA and directionally subcloned into 
pGEX-6p2 (GE Healthcare) using BamHI and EcoRI restriction enzymes. 
BL21 DE3 Escherichia coli were grown at 37°C to an OD600 of 0.6 and 
induced with 0.1 mM IPTG, and cells were shifted to 16°C for 18 h. Cells 
were centrifuged for 10 min at 2,100 g, and then, the pellets stored in buf-
fer A (PBS, 10 mM imidazole, and 0.1% -mercaptoethanol) at 80°C. 
Cells were lysed in buffer A by either sonication or using a cell disruptor 
(Avestin) and centrifuged at 23,000 g for 20 min at 4°C, and the superna-
tant was mixed with either Ni2+-NTA resin (QIAGEN), TALON cobalt resin 
(Takara Bio Inc.), or glutathione resin (GE Healthcare). Resins were washed 
in buffer A and eluted with either buffer A + 10 mM glutathione or a lin-
ear gradient of buffer A to buffer B (25 mM Tris, pH 8.0, 300 mM NaCl, 
300 mM imidazole, and 0.1% -mercaptoethanol). Protein-containing frac-
tions were pooled and dialyzed overnight in either buffer C (25 mM Hepes, 
pH 7.5, 300 mM NaCl, and 0.1% -mercaptoethanol) for SEC-MALS 
analysis or buffer D (25 mM Hepes, pH 7.4, 150 mM NaCl, and 1 mM 
DTT) for GST pull-down assays. Purified proteins were also concentrated 
using spin concentrators (Amicon Ultra; EMD Millipore). For in vitro bind-
ing assays, GST or GST–PB1-PB2 was immobilized on glutathione, mixed 
with His6-Asl-A or Asl-C, rocked at 25°C for 35 min, and pelleted at 500 g  
for 1 min. For Asl-C pull-down assays, GST or GST–PB1-PB2 were first chemi-
cally crossed linked to glutathione beads in buffer D by incubating with 
20 mM dimethyl pimelimidate dihydrochloride, pH 8.3, for 2 h at 22°C 
and then quenching the coupling reaction by incubating with 0.2 M etha-
nolamine, pH 8.3, for 1 h at 22°C. Supernatant and pellets were analyzed 
by SDS-PAGE.
SEC-MALS
Asl fragments were individually injected (50 µM; 100 µl) onto a Superdex 
200 10/300 GL size exclusion column (GE Healthcare) at 0.5 ml/min in 
buffer D (25 mM, Hepes, pH 7.5, 300 mM NaCl, 0.1% -mercaptoethanol, 
and 0.2 g/liter sodium azide) and then passed consecutively through a UV 
detector, a light scattering instrument (DAWN HELEOS II; Wyatt Technol-
ogy), and a refractometer (Optilab rEX; Wyatt Technology). The light scatter-
ing and refractive index data were used to calculate the weight-averaged 
Asl–Plk4 assembly, possibly similar to the aggregates observed 
in Asl–Plk4-overexpressing interphase cells, albeit on a smaller 
scale. Understanding how Plk4 centriolar spots form and then 
disassemble during mitotic exit is another important question. 
Modulating Asl activity may play a crucial role in the event be-
cause Plk4 ubiquitination alone may not efficiently remove the 
spot. We found that the second Plk4-binding domain within the 
C terminus enlarges the functional repertoire of Asl to include 
not only Plk4 centriole targeting but also opposing, cell cycle–
dependent effects that regulate Plk4 stability and activity. 
Future studies of the Asl–Plk4 interaction will provide a better 
understanding of how a mother centriole is mechanistically re-
stricted to the assembly of a single daughter centriole.
Materials and methods
Cell culture and double-stranded RNAi
Drosophila S2 cell culture, in vitro double-stranded RNA (dsRNA) synthe-
sis, and RNAi treatments were performed as previously described (Rogers 
and Rogers, 2008). In brief, cells were cultured in Sf-900 II serum-free 
media (Life Technologies). RNAi was performed in 6-well plates. Cells 
(50–90% confluency) were treated with 5 µg of dsRNA in 1 ml of media 
and replenished with fresh media/dsRNA every day for 4–7 d. A 550-bp 
control dsRNA was synthesized from DNA template amplified from a 
non-GFP sequence of the pEGFP-N1 vector (Takara Bio Inc.) using the 
primers 5-CGCTTTTCTGGATTCATCGAC-3 and 5-TGAGTAACCTG-
AGGCTATGG-3 (all primers used for dsRNA synthesis begin with the 
T7 promoter sequence 5-TAATACGACTCACTATAGGG-3). dsRNA was 
synthesized from cDNA using the primers against the following genes: 
Slimb, 5-GGCCGCCACATGCTGCG-3 and 5-CGGTCTTGTTCTCATT-
GGG-3; SAS-6, 5-ATGTGGCCTCCAGGGAGC-3 and 5-TGATGTT-
GGCCACATCCCC-3; Fizzy, 5-AAACTGCCTTCTTGGACGC-3 and 
5-ACTCATTCCTGGTTTCCTCTGG-3; Asl-A targeting exon, 5-GGAG-
GAGGAAGAGGCGC-3 and 5-GGCGTTCCGCTCCTCCC-3; and 
Asl-C targeting exon, 5-CGTCTGATCCATCGCCC-3 and 5-CATCG-
CCTCTTCGTGGG-3. dsRNA targeting the Asl UTR was synthesized 
from an EST template by first removing the Asl cDNA, joining 76 bp of 
5UTR with 114 bp of 3UTR, and amplified using the primers 5-GTT-
GCCTACGAAAATAGCGCC-3 and 5-TTTTGTTAGGAATGTACAGCG-3. 
Immunoblots confirmed that Asl UTR RNAi depleted endogenous Asl by 
70–80%, whereas Asl-A and Asl-C RNAi depleted endogenous Asl by 
over 90%. UTR RNAi was primarily used in replacement experiments, 
in which Asl-FL was expressed, otherwise Asl-A or Asl-C RNAi was used 
as indicated.
Immunofluorescence microscopy
For immunostaining, S2 cells were fixed and processed as previously de-
scribed (Rogers and Rogers, 2008) by spreading S2 cells on concanavalin 
A–coated, glass-bottom dishes and fixing with 10% formaldehyde. Primary 
antibodies were diluted to concentrations ranging from 1 to 20 µg/ml. They 
included rabbit anti-PLP (Rogers et al., 2009), guinea pig anti-Asl (Klebba 
et al., 2013), and mouse anti-V5 (Life Technologies) antibodies. Goat 
secondary antibodies (conjugated with Cy2, Rhodamine red-X, or Cy5; 
Jackson ImmunoResearch Laboratories, Inc.) were used at manufacturer-
recommended dilutions. Hoechst 33342 (Life Technologies) was used at 
a final dilution of 3.2 µM. Cells were mounted in 0.1 M n-propyl gallate, 
90% (by volume) glycerol, and 10% PBS solution. Specimens were im-
aged using a DeltaVision Core system (Applied Precision) equipped with 
a microscope (IX71; Olympus), a 100× objective (NA 1.4), and a cooled 
charge-coupled device camera (CoolSNAP HQ2; Photometrics). Images 
were acquired with softWoRx v1.2 software (Applied Precision). Super-
resolution microscopy was performed using a superresolution microscopy 
system for structured illumination (ELYRA S1; Carl Zeiss) equipped with an 
inverted microscope stand (Axio Observer.Z1; Carl Zeiss) with transmitted, 
UV, and solid-state (405/488/561 nm) laser illumination sources, a 60× 
objective (NA 1.4), and an electron-multiplying charge-coupled device 
camera (iXon; Andor Technology). Images were acquired with ZEN 2011 
software (Carl Zeiss).
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22°C, and then, the coupling reaction was quenched by incubating with 
0.2 M ethanolamine, pH 8.3, for 1 h at 22°C. Antibody-coated beads 
were washed three times with 1.5 ml of cell lysis buffer (CLB; 50 mM Tris, 
pH 7.2, 125 mM NaCl, 2 mM DTT, 0.1% Triton X-100, and 0.1 mM PMSF). 
Transfected cells expressing recombinant proteins were lysed in CLB, and the 
lysates were clarified by centrifugation at 20,000 g for 10 min at 4°C. 10% 
of the inputs were used for immunoblots. GBP-coated beads were rocked 
with lysate for 1 h at 4°C, washed two times with 1 ml CLB, and then boiled 
in Laemmli sample buffer. In vivo ubiquitination assays were performed by 
coexpressing Plk4-EGFP constructs with triple FLAG-tagged Drosophila Ubi 
(CG32744; also under the metallothionein promoter and Cu induced; Buster 
et al., 2013) and then probing the immunoblot of the cell lysate with mouse 
anti-FLAG antibody (Sigma-Aldrich).
Statistical analysis
Means of measurements were analyzed for significant differences by 
one-way analysis of variance (followed by Tukey’s post-test to evaluate 
differences between treatment pairs) using Prism 6 (GraphPad Software) 
software. Means are taken to be significantly different if P < 0.05. P-values 
shown for pairwise comparisons of Tukey’s post-test are adjusted for multi-
plicity. In the figures, a single asterisk indicates 0.05 > P ≥ 0.01, a double 
asterisk indicates 0.01 > P ≥ 0.001, a trouble asterisk indicates P < 
0.001, and NS indicates P > 0.05 for the indicated pairwise comparison. 
The Plk4 levels in Fig. 5 A were evaluated with the Wilcoxon signed rank 
test (Prism 6). Error bars in all figures indicate SEM.
Online supplemental material
Fig. S1 shows that transgenic Asl coimmunoprecipitates with endogenous 
Asl and self-interacts via Y2H, that Asl-C is predicted to form trimeric coiled 
coils, and that immunoblots of endogenous Asl replaced with Asl frag-
ments. Fig. S2 shows that Asl-C binds Plk4 PB1-PB2 and is sufficient to in-
duce centriole amplification and stabilize Plk4. Fig. S3 shows that the 
J11F10 mutant of Asl-C localizes to centrioles but fails to rescue centriole 
duplication in Asl-depleted cells. Fig. S4 shows images of centrioles in Asl- 
and Plk4-coexpressing cells. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201410105/DC1.
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